Propensity score-matching

Slides:

Advertisements

Similar presentations

MAIN-COMPARE Study – Disclosure Information

Advertisements

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Updates (CMS164) Change Review Process Meeting November 19, 2015 Jenna Williams-Bader.

Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Treatment Times Through Formalized.

Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:

Date of download: 7/7/2016 From: Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American.

From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.

Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.

From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:

Subgroup analyses for mortality after treatment with coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI). LAD, left anterior.

Risk stratification in ACS F.Shakib .cardiologigst

Robert A. Guyton, MD The Annals of Thoracic Surgery

Copyright © 2013 American Medical Association. All rights reserved.

Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.

Copyright © 2005 American Medical Association. All rights reserved.

Chapter 8: Cardiovascular Disease in Patients with ESRD

Initial pharmacotherapy for ST-segment elevation myocardial infarction

Initial pharmacotherapy for ST-segment elevation myocardial infarction

Volume 1: Chronic Kidney Disease

Stent Thrombosis Rates in Contemporary Clinical Practice: Insight from a Large Australian Multi-centre Registry BP Yan*, TJ Kiernan, SJ Duffy, DJ Clark,

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Ischaemic Heart Disease Acute Coronary Syndrome

Circ Cardiovasc Interv

Circ Cardiovasc Interv

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Glenn N. Levine et al. JACC 2016;68:

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Quality of Care in Chinese Hospitals: Processes and Outcomes After ST-segment Elevation Myocardial Infarction Nicholas S. Downing, MD; Yongfei Wang, MS;

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Chapter 4: Cardiovascular Disease in Patients with CKD

Robert A. Guyton, MD The Annals of Thoracic Surgery

Statins Evaluation in Coronary procedUres and REvascularization

New antiplatelet drugs and new oral anticoagulants

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease Glenn N. Levine, MD, FACC, FAHA,

Chapter 8: Cardiovascular Disease in Patients with ESRD

Efficacy of Xience/Promus versus Cypher to rEduce Late Loss in stENT

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction P.-G. Chassot, A. Delabays, D.R. Spahn

Characteristics of Contemporary Patients Discharged From the Hospital After an Acute Coronary Syndrome Robert J. Goldberg, PhD, Jane S. Saczynski, PhD,

Fig. 2. Evidence-based medication prescriptions

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Tornado diagram of one-way deterministic sensitivity analysis.

Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.

Measure-specific reasons for exclusion (2010-Q4–2013-Q3).

Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different.

Sajjad Raza, MD, Joseph F. Sabik, MD, Stephen G. Ellis, MD, Penny L

Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.

DEScover: One-Year Clinical Results

Rami Doukky et al. JCHF 2016;4:24-35

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Markov model scheme. Markov model scheme. Patients start (state 0) with uncomplicated PCI revascularisation; then cycle between health states until death.

DuyKhanh P. Ceppa, MD, Ian J. Welsby, MBBS, Tracy Y. Wang, MD, Mark W

(A) Multivariable Cox regressions showing the association of higher CHA2DS2-Vasc scores (≥6) and (B) R2CHA2DS2-Vasc scores (≥7) with 1-year mortality (CABG,

Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.

Figures showing the effects of a potential 30% relative reduction in events with next-generation drug-eluting stents in the percutaneous coronary intervention.

Leslee J. Shaw et al. JIMG 2010;3:

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Effect of methylprednisolone versus placebo on the risk of acute kidney injury: subgroup analysis by preoperative chronic kidney disease. Effect of methylprednisolone.

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

Kernel density plots of propensity score distributions in the included and excluded populations. Kernel density plots of propensity score distributions.

Cardiovascular Epidemiology and Epidemiological Modelling

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy Andrea M. Steely, MD, Peter W.

Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.

Presentation transcript:

Propensity score-matching A total 53281 AMI patients from January 2005 to June 2015 in the KAMIR Registry Exclusion Uncertainty of diagnosis (n=475) PCI was not done, Failed (n=3329), CABG (n=135) BMS deployment (n=2441) Follow-up loss (n=3729) Not participated (n=1229) Incomplete laboratory results (n=6756) ACEI or ARB were contraindicated or not prescribed (n=10477) Finally, 24960 AMI Patients who underwent PCI with DES and prescribed the RASI were enrolled STEMI (n=14061) NSTEMI (n=10899) Propensity score-matching STEMI (n=6762) NSTEMI (n=6762) Supplement 1. Flow chart. AMI, acute myocardial infarction; KAMIR, Korea Acute Myocardial Infarction Registry; PCI, percutaneous coronary intervention; BMS, bare-metal stent; CABG, coronary artery bypass graft; DES, drug-eluting stents; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blockers; RASI, renin-angiotensin system inhibitors.